Timed Ang2-Targeted Therapy Identifies the Angiopoietin–Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis

MLA

Ling Hai, et al. “Timed Ang2-Targeted Therapy Identifies the Angiopoietin–Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis.” Cancer Discovery, vol. 11, Feb. 2021, pp. 424–45. EBSCOhost, https://doi.org/10.1158/2159-8290.cd-20-0122.

APA

Ling Hai, Matthias Schlesner, Stephanie Gehrs, Nicolas Gengenbacher, Daniel Baumann, Mahak Singhal, Rienk Offringa, Sudhakar Chintharlapalli, Hellmut G. Augustin, Junhao Hu, Claudine Fricke, Ashik Ahmed Abdul Pari, Jochen Utikal, Laura Milde, Moritz Felcht, Eva Besemfelder, & Carolin Mogler. (2021). Timed Ang2-Targeted Therapy Identifies the Angiopoietin–Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis. Cancer Discovery, 11, 424–445. https://doi.org/10.1158/2159-8290.cd-20-0122

Chicago

Ling Hai, Matthias Schlesner, Stephanie Gehrs, Nicolas Gengenbacher, Daniel Baumann, Mahak Singhal, Rienk Offringa, et al. 2021. “Timed Ang2-Targeted Therapy Identifies the Angiopoietin–Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis.” Cancer Discovery 11 (February): 424–45. doi:10.1158/2159-8290.cd-20-0122.